fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

FluMist nasal spray approved for self-administration in the US – AstraZeneca

Written by | 26 Sep 2024

FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49… read more.

Positive phase III results show Xofluza (baloxavir marboxil) significantly reduces the transmission of influenza viruses – Genentech/Roche

Written by | 24 Sep 2024

Genentech, a member of the Roche Group , announced t positive topline results of the Phase III CENTERSTONE study of Xofluza (baloxavir marboxil), an antiviral, showing a reduction in… read more.

Study shows promise for a universal influenza vaccine

Written by | 21 Jul 2024

New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine — a so-called “one and done” vaccine that confers… read more.

Molecule produced in gut may protect against flu

Written by | 8 Jul 2024

A naturally occurring molecule could help to prevent – and even treat – influenza, according to a new study published in the journal Gut Microbes. The molecule, indole-3-propionic… read more.

Flu vaccines to target three virus strains this autumn

Written by | 7 Jul 2024

Vaccine manufacturers have been tasked with producing vaccines that protect against three influenza viruses, as Europe gears up for another flu season. Companies are actively producing millions of… read more.

Simple test for flu could improve diagnosis and surveillance

Written by | 25 Jun 2024

Fewer than one percent of people who get the flu every year get tested, in part because most tests require trained personnel and expensive equipment. Now researchers have… read more.

EU recommendations for seasonal flu vaccine composition

Written by | 7 Apr 2024

The winter flu season may be over in the northern hemisphere, but EU regulators are already looking ahead to the next outbreak in autumn 2024. Influenza viruses continuously… read more.

‘Long flu’ has emerged as a consequence similar to long COVID

Written by | 21 Dec 2023

Since the COVID-19 pandemic began, extensive research has emerged detailing the virus’s ability to attack multiple organ systems, potentially resulting in a set of enduring and often disabling… read more.

FDA accepts for review supplemental biologics license application for self-administration of FluMist Quadrivalent – AstraZeneca

Written by | 30 Oct 2023

Potential to be the first and only self-administered flu vaccine ; AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist… read more.

Decreased influenza prevalence potentially associated with public health measures against COVID-19

Written by | 1 Jan 2023

A recent study provides preliminary evidence of the long-term relationship between prevention and control measures and influenza transmission in China during the COVID-19 pandemic, accounting for the impact… read more.

National poll: 1 in 7 parents haven’t discussed vaccines with their child’s primary care provider during pandemic period

Written by | 22 Nov 2022

Parents may not always turn to health professionals for vaccine advice – and a small subset could even be avoiding the conversation – a new national poll suggests…. read more.

Study hints at why older people are more susceptible to the flu

Written by | 12 Nov 2022

Though the COVID-19 pandemic provided a brief respite, influenza virus is back in circulation and, as usual, poses a special danger to people over the age of 65…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.